BUZZ-Illumina falls after lower-than-expected 2025 revenue forecast

Shares of gene sequencing equipment maker Illumina ILMN.O fall 4.7% to $117 premarket

Co, late on Thursday, forecast 2025 revenue largely below Wall Street estimates

Co expects 2025 revenue between $4.28 bln and $4.40 bln, below analysts' average estimate of $4.39 bln at midpoint, according to data compiled by LSEG

China, which accounts for about 7% of Illumina's sales, placed co on its "unreliable entity" list earlier this week

Illumina said its forecast does not reflect any impact from announcement from China

"The lack of adjusting could mean there's hope they could be removed from the 'unreliable entity list' or that they can't yet quantify it" - Piper Sandler analysts

Up to last close, stock down ~12% in the past 12 months